ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PHGN Pharming Group NV

0.8565
-0.0015 (-0.17%)
07:06:53 - Realtime Data
Company Name Stock Ticker Symbol Market Type
Pharming Group NV PHGN Tradegate Ordinary Share
  Price Change Change Percent Stock Price Last Traded
-0.0015 -0.17% 0.8565 07:06:53
Open Price Low Price High Price Close Price Prev Close
0.8625 0.854 0.8625 0.858
more quote information »

Recent News

Date Time Source Heading
5/16/20248:13IHNWFeaturedCannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology
5/15/202401:00GLOBEPharming Group announces the early redemption of the..
5/08/202401:00GLOBEPharming Group reports first quarter 2024 financial results..
4/24/202402:00GLOBEPharming Group to report first quarter 2024 financial..
4/24/202401:00GLOBEPharming to be honored as Industry Innovator at National ..
4/19/202412:43GLOBEPharming Group announces the repurchase of outstanding €125..
4/18/202409:04GLOBEPharming Group announces the placement of €100 million..
4/18/202402:00GLOBEPharming Group announces the launch of an offering of..
4/08/202401:00GLOBEPharming announces completion of enrollment in pediatric..
4/04/202402:30GLOBEPharming Group announces the 2024 Annual General Meeting of..
4/04/202401:00GLOBEPharming Group announces the filing of its 2023 Annual..
4/03/202402:00GLOBEPharming Group to participate in April investor conferences
3/14/202402:00GLOBEPharming Group reports fourth quarter and full year 2023..
2/29/202402:00GLOBEPharming Group to report fourth quarter and full year 2023..
2/08/202402:00GLOBEPharming Group to participate in February investor..
1/08/202401:00GLOBEPharming Group announces updated full year 2023 guidance and..
12/13/202301:00GLOBEPharming Group announces development plans for leniolisib..
11/21/202301:00GLOBEPharming announces first patient dosed in pediatric clinical..
11/10/202308:51GLOBEPharming Group provides updates on EMA regulatory review of..
11/01/202303:00GLOBEPharming Group to participate in November investor..
10/26/202301:00GLOBEPharming Group reports third quarter 2023 financial results
10/12/202302:00GLOBEPharming Group to report third quarter 2023 financial..
9/25/202310:00GLOBEPharming Group reports on results of the 2023 Extraordinary..